Search

everythinglearnresearchcommunity

for

Search:↓

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Dutch dermatologists prioritized skin conditions like melanoma and psoriasis for guideline development, focusing on consistent care over cost or death rates.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Suppressing certain hormones might help prevent prostate cancer.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Males and females differ in lifespan, growth, organ size, metabolism, and brain structure, with females generally living longer and maturing earlier.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Genetic differences affect COVID-19 severity and treatment effectiveness.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Finasteride is safe for long-term use in prostate cancer treatment.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Testosterone may both worsen and protect against COVID-19 effects in men.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.